140 related articles for article (PubMed ID: 3370193)
1. Mephenytoin hydroxylation in the Cuna Amerindians of Panama.
Inaba T; Jorge LF; Arias TD
Br J Clin Pharmacol; 1988 Jan; 25(1):75-9. PubMed ID: 3370193
[TBL] [Abstract][Full Text] [Related]
2. Mephenytoin and sparteine pharmacogenetics in Canadian Caucasians.
Inaba T; Jurima M; Nakano M; Kalow W
Clin Pharmacol Ther; 1984 Nov; 36(5):670-6. PubMed ID: 6488688
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and Caucasians.
Jurima M; Inaba T; Kadar D; Kalow W
Br J Clin Pharmacol; 1985 Apr; 19(4):483-7. PubMed ID: 3994895
[TBL] [Abstract][Full Text] [Related]
4. Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism.
Wedlund PJ; Aslanian WS; McAllister CB; Wilkinson GR; Branch RA
Clin Pharmacol Ther; 1984 Dec; 36(6):773-80. PubMed ID: 6499356
[TBL] [Abstract][Full Text] [Related]
5. Family studies of mephenytoin hydroxylation deficiency.
Inaba T; Jurima M; Kalow W
Am J Hum Genet; 1986 May; 38(5):768-72. PubMed ID: 3717162
[TBL] [Abstract][Full Text] [Related]
6. Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylation.
Küpfer A; Branch RA
Clin Pharmacol Ther; 1985 Oct; 38(4):414-8. PubMed ID: 4042524
[TBL] [Abstract][Full Text] [Related]
7. Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations.
Nakamura K; Goto F; Ray WA; McAllister CB; Jacqz E; Wilkinson GR; Branch RA
Clin Pharmacol Ther; 1985 Oct; 38(4):402-8. PubMed ID: 4042523
[TBL] [Abstract][Full Text] [Related]
8. A major pathway of mephenytoin metabolism in man. Aromatic hydroxylation to p-hydroxymephenytoin.
Küpfer A; Brilis GM; Watson JT; Harris TM
Drug Metab Dispos; 1980; 8(1):1-4. PubMed ID: 6102023
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphism of mephenytoin metabolism.
Inaba T
Prog Clin Biol Res; 1986; 214():139-56. PubMed ID: 3523505
[No Abstract] [Full Text] [Related]
10. Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man.
Küpfer A; Preisig R
Eur J Clin Pharmacol; 1984; 26(6):753-9. PubMed ID: 6489416
[TBL] [Abstract][Full Text] [Related]
11. Phenotyping polymorphic drug metabolism in the French Caucasian population.
Jacqz E; Dulac H; Mathieu H
Eur J Clin Pharmacol; 1988; 35(2):167-71. PubMed ID: 3191936
[TBL] [Abstract][Full Text] [Related]
12. S-mephenytoin 4-hydroxylase is inherited as an autosomal-recessive trait in Japanese families.
Ward SA; Goto F; Nakamura K; Jacqz E; Wilkinson GR; Branch RA
Clin Pharmacol Ther; 1987 Jul; 42(1):96-9. PubMed ID: 3595072
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism of S-mephenytoin hydroxylation.
Wilkinson GR; Guengerich FP; Branch RA
Pharmacol Ther; 1989; 43(1):53-76. PubMed ID: 2675129
[No Abstract] [Full Text] [Related]
14. Oxidative metabolism of hexobarbital in human liver: relationship to polymorphic S-mephenytoin 4-hydroxylation.
Knodell RG; Dubey RK; Wilkinson GR; Guengerich FP
J Pharmacol Exp Ther; 1988 Jun; 245(3):845-9. PubMed ID: 3385644
[TBL] [Abstract][Full Text] [Related]
15. Stereoselectivity of the arene epoxide pathway of mephenytoin hydroxylation in man.
Küpfer A; Lawson J; Branch RA
Epilepsia; 1984 Feb; 25(1):1-7. PubMed ID: 6420144
[TBL] [Abstract][Full Text] [Related]
16. Relationship between mephenytoin oxidation polymorphism and phenytoin, methylphenytoin and phenobarbitone hydroxylation assessed in a phenotyped panel of healthy subjects.
Schellens JH; van der Wart JH; Breimer DD
Br J Clin Pharmacol; 1990 Jun; 29(6):665-71. PubMed ID: 2378787
[TBL] [Abstract][Full Text] [Related]
17. Mephenytoin and sparteine oxidation: genetic polymorphisms in Denmark.
Drøhse A; Bathum L; Brøsen K; Gram LF
Br J Clin Pharmacol; 1989 May; 27(5):620-5. PubMed ID: 2757884
[TBL] [Abstract][Full Text] [Related]
18. The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation.
Meyer UA; Gut J; Kronbach T; Skoda C; Meier UT; Catin T; Dayer P
Xenobiotica; 1986 May; 16(5):449-64. PubMed ID: 2874666
[TBL] [Abstract][Full Text] [Related]
19. Mephenytoin hydroxylation polymorphism: characterization of the enzymatic deficiency in liver microsomes of poor metabolizers phenotyped in vivo.
Meier UT; Dayer P; Malè PJ; Kronbach T; Meyer UA
Clin Pharmacol Ther; 1985 Nov; 38(5):488-94. PubMed ID: 4053486
[TBL] [Abstract][Full Text] [Related]
20. The oxidative metabolism of sparteine in the Cuna Amerindians of Panama: absence of evidence for deficient metabolizers.
Arias TD; Jorge LF; Lee D; Barrantes R; Inaba T
Clin Pharmacol Ther; 1988 Apr; 43(4):456-65. PubMed ID: 3356089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
